Withdrawal symptoms can also occur when individuals stop taking GLP-1 medications: Reduced side effects: While semaglutide or tirzepatide can lead to side effects like acid reflux, nausea, constipation and abdominal pain, stopping the medication can reduce these side effects
As the dosage increases over time, the appetite-suppressing effects often become stronger and more consistent, helping patients develop healthier eating habits and steady progress toward their weight-loss goals
Cardiovascular outcomes trials in type 2 diabetes: where do we go from here
Our program fees will be reviewed at your consultation
There are also two stop and seek care signals worth stating plainly as reference context, because they are the classs more serious events: severe, persistent abdominal pain (which may radiate to the back and can signal pancreatitis) and symptoms of gallbladder disease such as right-upper-quadrant pain, fever, or jaundice
SURMOUNT-4 trial results: The impact of tirzepatide on maintenance of weight reduction and benefits of continued therapy
